Kyongbo Pharmaceutical Co., Ltd Withdrawn
CEP Certificates (EDQM COS List)

Kyongbo Pharmaceutical Co., Ltd Withdrawn

CEP Database

Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.

Chemical South Korea
  • Total Records 6
  • Latest End Date 2021-07-27
  • Data Source EDQM
  • Last Updated 2018-11-21
All
10
View
Valid
3
View
Withdrawn
6
View
Expired
1
View
Company Overview

Company

Kyongbo Pharmaceutical Co., Ltd Withdrawn

Country

South Korea

Social Profiles

Company Snapshot

Kyongbo Pharmaceutical Co., Ltd Withdrawn

174, Sirok-Ro, Asan-Si, Chungcheongnam-Do, 336-020, Korea

South Korea

www.kbpharma.co.kr/ skarajjang@kbpharma.co.kr View on Map
CEP Records Timeline (6 records)
2018
21 Nov
Chemical Withdrawn by Holder

Product

Ceftazidime Pentahydrate, Sterile

Substance

KYONGBO PHARMACEUTICAL CO., LTD. Asan-si KR

Certificate No.

R1-CEP 2011-390 - Rev 00

Substance No.

1405

Issue Date

2018-11-21

End Date

2021-07-27

South Korea

Country

South Korea

Identifiers

Certificate No.: R1-CEP 2011-390 - Rev 00
Substance No.: 1405

2016
02 Dec
Chemical Withdrawn by Holder

Product

Cefixime

Substance

KYONGBO PHARMACEUTICAL CO., LTD. Asan-si KR

Certificate No.

R0-CEP 2014-217 - Rev 00

Substance No.

1188

Issue Date

2016-12-02

End Date

2021-07-12

South Korea

Country

South Korea

Identifiers

Certificate No.: R0-CEP 2014-217 - Rev 00
Substance No.: 1188

2016
04 Nov
Chemical Withdrawn by Holder

Product

Entacapone

Substance

KYONGBO PHARMACEUTICAL CO., LTD. Asan-si KR

Certificate No.

R0-CEP 2015-168 - Rev 00

Substance No.

2574

Issue Date

2016-11-04

End Date

2021-07-12

South Korea

Country

South Korea

Identifiers

Certificate No.: R0-CEP 2015-168 - Rev 00
Substance No.: 2574

2016
02 Nov
Chemical Withdrawn by Holder

Product

Raloxifene hydrochloride

Substance

KYONGBO PHARMACEUTICAL CO., LTD. Asan-si KR

Certificate No.

R0-CEP 2015-174 - Rev 00

Substance No.

2375

Issue Date

2016-11-02

End Date

2021-07-12

South Korea

Country

South Korea

Identifiers

Certificate No.: R0-CEP 2015-174 - Rev 00
Substance No.: 2375

2015
03 Dec
Chemical Withdrawn by Holder

Product

Cefaclor

Substance

KYONGBO PHARMACEUTICAL CO., LTD. Asan-si KR

Certificate No.

R1-CEP 2006-306 - Rev 01

Substance No.

986

Issue Date

2015-12-03

End Date

2021-07-12

South Korea

Country

South Korea

Identifiers

Certificate No.: R1-CEP 2006-306 - Rev 01
Substance No.: 986

2014
07 Apr
Chemical Withdrawn by Holder

Product

Meropenem trihydrate, Synthetic origin, sterile

Substance

KYONGBO PHARMACEUTICAL CO., LTD. Asan-Si KR

Certificate No.

R0-CEP 2012-089 - Rev 00

Substance No.

2234

Issue Date

2014-04-07

End Date

2018-10-22

South Korea

Country

South Korea

Identifiers

Certificate No.: R0-CEP 2012-089 - Rev 00
Substance No.: 2234

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    10 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
Status Breakdown
6 total
  • Withdrawn by holder
Official Source

All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).

Visit EDQM
Record Details Preview

Click "View Details" on any record above to expand full details inline.

Country

South Korea

Identifiers

Certificate No.: R1-CEP 2011-390 - Rev 00
Substance No.: 1405

100% Official Data

Directly from the EDQM CEP database

Regular Updates

Data updated regularly from official sources

Trusted by Professionals

100K+ pharma professionals worldwide

Secure & Reliable

Enterprise-grade security and data protection

CEP data is obtained from the official EDQM (European Directorate for the Quality of Medicines) database.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.